DataMEDS AI, Inc. (MEDS)
$2.75+3.00%Close
Snapshot
- 1 week
- -9.2%-8.1% vs SPY
- 1 month
- -26.9%-27.8% vs SPY
- Market cap
- $6.8M
- P/E
- negindustry 14.3
- P/B
- -0.4
- EV/EBITDA
- -0.7
- Short % float
- 50.0%
- Days to cover
- 1.0
- Short change
- +21.9%
Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year
Price & returns: 3 years, 5 years
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
DataMEDS AI, Inc. (MEDS). DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx⢠and blockchain-enabled smart contacts platform PharmacyChain⢠to optimize the prescription medicines reimbursement and dispensing journey.
SEC filingsCIK 2030763
Profile
SectorHealthcare
IndustryMedical - Distribution
ExchangeNASDAQ
CountryUS
CEOPrashant Patel
IPOFeb 21, 2025
Employees31
Shares outstanding2.5M
Float1.1M
Free float-
Websitedatamedsai.com
Key executives
- Gerald E. CommissiongInterim Co-Chief Executive Officer
- Shafaat PiraniChief Clinical OfficerUSD 275K
- Srini KallaChief Technology OfficerUSD 233K
- Eric Michael SherbInterim-CFOUSD 182K
- Prashant PatelInterim Co-CEO, President & DirectorUSD 13K
- Nikul PanchalSenior Vice President of Pharmacy
